Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP

被引:28
作者
Chassain, C [1 ]
Eschalier, A [1 ]
Durif, F [1 ]
机构
[1] Fac Med & Pharm, INSERM, U9904, EMI, F-63003 Clermont Ferrand, France
关键词
monkey; video image analyzer system; clinical rating scales; motor behavior assessment; MPTP; levodopa;
D O I
10.1016/S0165-0270(01)00425-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The best current model of Parkinson's disease is the primate treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Quantification of animal movement is important for the study of severity of parkinsonian syndrome induced by MPTP and response to drug treatments. Both require clinical rating scales that measure motor behavior with well-defined objective items. However, evaluations using these scales depend on the observer scoring the different items, according to his/her experience. The video image analyzer system, which produces an activity curve in correlation with the visual study of animal motor behavior, offers an automatic evaluation method that is observer-independent and reproducible. Using such an system we defined items correlated with those used in clinical rating scales that are sensitive to animal motor changes, decrease in movements with MPTP intoxication and alleviation afforded by levodopa: global locomotor activity and specific activities (climbing, social interactions, eating and drinking behaviors). (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 24 条
[1]   FUNCTIONAL ARCHITECTURE OF BASAL GANGLIA CIRCUITS - NEURAL SUBSTRATES OF PARALLEL PROCESSING [J].
ALEXANDER, GE ;
CRUTCHER, MD .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :266-271
[2]  
BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5
[3]   A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey [J].
Bezard, E ;
Imbert, C ;
Deloire, X ;
Bioulac, B ;
Gross, CE .
BRAIN RESEARCH, 1997, 766 (1-2) :107-112
[4]   EXCITOTOXIC LATERAL PALLIDOTOMY DOES NOT RELIEVE L-DOPA-INDUCED DYSKINESIA IN MPTP PARKINSONIAN MONKEYS [J].
BLANCHET, PJ ;
BOUCHER, R ;
BEDARD, PJ .
BRAIN RESEARCH, 1994, 650 (01) :32-39
[5]   Chronic exposure to MPTP as a primate model of progressive parkinsonism: A pilot study with a free radical scavenger [J].
Blanchet, PJ ;
Konitsiotis, S ;
Hyland, K ;
Arnold, LA ;
Pettigrew, KD ;
Chase, TN .
EXPERIMENTAL NEUROLOGY, 1998, 153 (02) :214-222
[6]  
Blanchet PJ, 1997, J PHARMACOL EXP THER, V283, P794
[7]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[8]   RAPID ATP LOSS CAUSED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN MOUSE-BRAIN [J].
CHAN, P ;
DELANNEY, LE ;
IRWIN, I ;
LANGSTON, JW ;
DIMONTE, D .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) :348-351
[9]  
Emborg ME, 1998, J COMP NEUROL, V401, P253
[10]   EFFECT OF ADDING THE D1 AGONIST CY 208-243 TO CHRONIC BROMOCRIPTINE TREATMENT .1. EVALUATION OF MOTOR PARAMETERS IN RELATION TO STRIATAL CATECHOLAMINE CONTENT AND DOPAMINE-RECEPTORS [J].
GOMEZMANCILLA, B ;
BOUCHER, R ;
GAGNON, C ;
DIPAOLO, T ;
MARKSTEIN, R ;
BEDARD, PJ .
MOVEMENT DISORDERS, 1993, 8 (02) :144-150